BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 31486483)

  • 1. MiR-574-3p exerts as a tumor suppressor in ovarian cancer through inhibiting MMP3 expression.
    Zheng J; Zhou Y; Li XJ; Hu JM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6839-6848. PubMed ID: 31486483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
    Gong YB; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circ-CSPP1 promotes proliferation, invasion and migration of ovarian cancer cells by acting as a miR-1236-3p sponge.
    Li QH; Liu Y; Chen S; Zong ZH; Du YP; Sheng XJ; Zhao Y
    Biomed Pharmacother; 2019 Jun; 114():108832. PubMed ID: 30965236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
    Qiao B; Wang Q; Zhao Y; Wu J
    Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
    Xu H; Mao HL; Zhao XR; Li Y; Liu PS
    J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
    Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1 Is Targeted by miR-519a-3p and Promotes the Migration, Invasion, and Tube Formation of Ovarian Cancer Cells.
    Chang H; Zhang X; Li B; Meng X
    Cancer Biother Radiopharm; 2022 Nov; 37(9):824-836. PubMed ID: 34009012
    [No Abstract]   [Full Text] [Related]  

  • 10. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
    Xu C; Zhu LX; Sun DM; Yao H; Han DX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
    Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
    Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-324-3p suppresses the aggressive ovarian cancer by targeting
    Li F; Liang Z; Jia Y; Zhang P; Ling K; Wang Y; Liang Z
    Bioengineered; 2022 May; 13(5):12030-12044. PubMed ID: 35549643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.
    Sun C; Liu XH; Sun YR
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6927-6934. PubMed ID: 31486492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.
    Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W
    Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene.
    Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S
    Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6.
    Wang Y; Lei X; Gao C; Xue Y; Li X; Wang H; Feng Y
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
    Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-342-3p inhibits cell migration and invasion through suppressing forkhead box protein Q1 in ovarian carcinoma.
    Wang C; Zhang W; Xing S; Wang Z; Wang J; Qu J
    Anticancer Drugs; 2019 Oct; 30(9):917-924. PubMed ID: 31517731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer.
    Wang Z; Zhang X; Liu Y; Shi X; Li L; Jia Y; Wu F; Cui H; Li L
    Histol Histopathol; 2023 Dec; 38(12):1403-1413. PubMed ID: 36825753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.